No-reflow phenomenon and acute myocardial ischemia. The need for further investigation
Insights
The no-reflow phenomenon, characterized by capillary obstruction after reperfusion, damages the vascular bed. This microcirculatory defect can lead to irreversible myocardial damage and reperfusion injury.
Area of Science:
- Cardiovascular Science
- Pathophysiology
- Microcirculation Research
Background:
- Localized myocardial ischemia causes microvascular changes.
- The no-reflow phenomenon, characterized by capillary obstruction upon reperfusion, affects various organs including the myocardium.
- Ultrastructural studies implicate myocardial and endothelial cell swelling in this process.
Purpose of the Study:
- To investigate the role of microvascular changes and the no-reflow phenomenon in myocardial ischemia.
- To understand the implications of the no-reflow phenomenon in irreversible ischemic damage and reperfusion injury.
- To explore the potential involvement of the no-reflow phenomenon in specific cardiac conditions.
Main Methods:
- Review of ultrastructural studies on myocardial and endothelial cell swelling.
- Analysis of clinical and experimental observations related to reperfusion injury.
- Examination of microcirculatory defects in conditions like subendocardial necrosis.
Main Results:
- The no-reflow phenomenon involves capillary obstruction following reperfusion after ischemia.
- Damage to the vascular bed, including cell swelling, may be an early irreversible change.
- This phenomenon is linked to reperfusion injury and failure of successful myocardial reperfusion.
Conclusions:
- The no-reflow phenomenon is a significant factor in myocardial ischemia and reperfusion.
- It may contribute to subendocardial necrosis and myocytolytic necrosis.
- Further research is necessary to elucidate underlying mechanisms and therapeutic strategies.
Abstract:
It has been shown that localized myocardial ischemia is accompanied by microvascular changes which produce capillary obstruction when blood flow is restored. This so-called no-reflow phenomenon has been noted in the brain, kidney, dermis and, more recently, in the myocardium. Ultrastructural studies have pointed out the role of myocardial and endothelial cells swelling. It seems likely that such damage of the vascular bed may constitute the first irreversible change during ischemia and result in failure to obtain successful reperfusion of involved myocardium. It can be suggested on the basis of recent clinical and experimental observations, that this phenomenon may play a role in subendocardial necrosis associated with cardiac surgery, and in myocytolytic necrosis. In both of these conditions, the most salient features are the microcirculatory defect and the reperfusion injury following transient ischemia. Further investigations are needed to determine the basic alterations induced by no-reflow phenomenon and the value of various prophylactic and therapeutic measures.
Related Concept Videos
01:30Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
01:21Myocarditis I: Introduction
01:27Myocarditis II: Clinical Features and Diagnostic Tests
01:30Acute Coronary Syndrome I: Introduction
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Acute Coronary Syndrome III: Diagnostic Studies